These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27117493)

  • 1. Severe, reversible nelarabine-induced neuropathy and myelopathy.
    Alberti P; Parma M; Pioltelli P; Pogliani EM; Terruzzi E; Stasia A; Doni E; Cecchetti C; Cavaletti G
    J Peripher Nerv Syst; 2016 Sep; 21(3):154-6. PubMed ID: 27117493
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric T-ALL complicated by irreversible nelarabine neurotoxicity.
    Kanayama T; Imamura T; Nakagawa N; Osone S; Hosoi H
    Pediatr Int; 2017 Jul; 59(7):843-845. PubMed ID: 28745456
    [No Abstract]   [Full Text] [Related]  

  • 3. MR imaging in nelarabine-induced myelopathy.
    Dua SG; Jhaveri MD
    J Clin Neurosci; 2016 Jul; 29():205-6. PubMed ID: 26899359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia.
    Gollard RP; Selco S
    J Clin Oncol; 2013 Jul; 31(19):e327-31. PubMed ID: 23715575
    [No Abstract]   [Full Text] [Related]  

  • 5. Nelarabine-associated reversible Guillain-Barré-like syndrome or myelopathy in an adult patient with primary refractory T-lymphoblastic lymphoma.
    Lalayanni C; Baldoumi E; Papayiannopoulos S; Tziola K; Saloum R; Anagnostopoulos A
    Curr Probl Cancer; 2017; 41(2):138-143. PubMed ID: 28169005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nelarabine-associated myelopathy in a patient with acute lymphoblastic leukaemia: Case report.
    Amer-Salas N; González-Morcillo G; Rodríguez-Camacho JM; Cladera-Serra A
    J Oncol Pharm Pract; 2021 Jan; 27(1):244-249. PubMed ID: 32517638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature.
    Ngo D; Patel S; Kim EJ; Brar R; Koontz MZ
    J Oncol Pharm Pract; 2015 Aug; 21(4):296-300. PubMed ID: 24664478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nelarabine-induced peripheral and central neurotoxicity: can sequential MRI brain imaging help to define its natural history?
    Ewins K; Malone A; Phelan E; Webb D; McHugh JC; Smith O
    Br J Haematol; 2017 Oct; 179(2):294-297. PubMed ID: 28961308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
    Papayannidis C; Iacobucci I; Abbenante MC; Curti A; Paolini S; Parisi S; Baccarani M; Martinelli G
    Am J Hematol; 2010 Aug; 85(8):608. PubMed ID: 20658590
    [No Abstract]   [Full Text] [Related]  

  • 10. Coma associated with nelarabine in an elderly patient with T-cell acute lymphoblastic leukemia and severe chronic renal disease.
    Nishijima TF; Shea TC; Wood WA; Voorhees PM; Jamieson K
    Leuk Lymphoma; 2016; 57(4):957-60. PubMed ID: 26293208
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
    Hartz B; Löbel U; Hagel C; Escherich G
    Am J Hematol; 2013 Dec; 88(12):1096-7. PubMed ID: 23873785
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Dunsmore KP; Devidas M; Linda SB; Borowitz MJ; Winick N; Hunger SP; Carroll WL; Camitta BM
    J Clin Oncol; 2012 Aug; 30(22):2753-9. PubMed ID: 22734022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of nelarabine in adults with relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma.
    Candoni A; Lazzarotto D; Petruzzellis G
    Expert Opin Drug Saf; 2021 Jul; 20(7):751-756. PubMed ID: 33866913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Findings in Children Presenting with CNS Nelarabine Toxicity.
    Serrallach BL; Schafer ES; Kralik SK; Tran BH; Huisman TAGM; Wright JN; Morgan LA; Desai NK
    AJNR Am J Neuroradiol; 2022 Dec; 43(12):1802-1809. PubMed ID: 36328408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe liver injury following nelarabine chemotherapy for T-cell lymphoblastic lymphoma].
    Iino M
    Rinsho Ketsueki; 2009 Jan; 50(1):49-51. PubMed ID: 19225230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia.
    Pehlivan UA; Gürkan E; Açar İH; Bıçakcı YK
    J Oncol Pharm Pract; 2023 Jan; 29(1):246-251. PubMed ID: 35593112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.
    Kuhlen M; Bleckmann K; Möricke A; Schrappe M; Vieth S; Escherich G; Bronsema A; Vonalt A; Queudeville M; Zwaan CM; Ebinger M; Debatin KM; Klingebiel T; Koscielniak E; Rossig C; Burkhardt B; Kolb R; Eckert C; Borkhardt A; von Stackelberg A; Chen-Santel C
    Br J Haematol; 2017 Oct; 179(2):272-283. PubMed ID: 28771662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of cancer chemotherapy.
    Dropcho EJ
    Semin Neurol; 2010 Jul; 30(3):273-86. PubMed ID: 20577934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicoradiological dissociation in sarcoid myelopathy.
    Dhanapalaratnam R; Huynh W
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1227-1228. PubMed ID: 32855287
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
    Mantadakis E; Amoiridis G; Kondi A; Kalmanti M
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):130. PubMed ID: 17279013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.